Modular Medical Secures Nasdaq Compliance, Averting Delisting Threat
MODD sits 38% above its 52-week low of $3.552.
Summary
Modular Medical, Inc. announced it has regained compliance with the Nasdaq Capital Market's minimum bid price requirement, having maintained a closing bid price above $1.00 for 10 consecutive trading days. This positive development removes the immediate threat of delisting, which is crucial for investor confidence and future capital access for the small-cap medical device company. This compliance follows the recent FDA 510(k) clearance for its Pivot tubeless insulin patch pump on April 9th, which likely contributed to the stock price recovery. However, traders should note that the company's last 10-Q in February disclosed a significant liquidity crisis and substantial doubt about its ability to continue as a going concern. While delisting risk is mitigated, the market will now focus on how Modular Medical plans to address its underlying financial challenges.
At the time of this announcement, MODD was trading at $4.89 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $21.8M. The 52-week trading range was $3.55 to $34.50. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Access Newswire.